Zero incidence of factor VIII inhibitors and successful haemostatic response in previously factor VIII‐treated patients with haemophilia A switching to turoctocog alfa in a noninterventional study-Reference-Cited by-同舟云学术

Zero incidence of factor VIII inhibitors and successful haemostatic response in previously factor VIII‐treated patients with haemophilia A switching to turoctocog alfa in a noninterventional study

Published:2021-11-17 Issue:1 Volume:28 Page:46-54
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Escuriola Ettingshausen Carmen¹,Katsarou Olga²,Kotnik Barbara Faganel³,Borel Derlon Annie⁴,Schwarz Rudolf⁵,Ypma Paula F.⁶,Matytsina Irina⁷,Dey Sohan⁸,Schutgens Roger E. G.⁹^ORCID

Affiliation:

1. HZRM Hämophilie Zentrum Rhein Main GmbH Mörfelden‐Walldorf Germany

2. Haemophilia Centre Laiko Hospital Athens Greece

3. University Children's Hospital Ljubljana Slovenia

4. CHU de Caen ‐ Hôpital de la Côte de Nacre Caen France

5. Landes Frauen ‐ und Kinderklinik, Linz Austria

6. Department of Hematology Hagaziekenhuis The Hague The Netherlands

7. Novo Nordisk A/S, Søborg Denmark

8. Novo Nordisk Service Centre India Private Ltd. Bangalore India

9. Van Creveldkliniek University Medical Centre and University, Utrecht The Netherlands

Publisher

Wiley